Andreas Strauss

Title: Innovations by Andreas Strauss in Cancer Treatment

Introduction

Andreas Strauss is a notable inventor based in Penzberg, Germany. He has made significant contributions to the field of cancer treatment, particularly through his innovative patents. With a total of 3 patents, Strauss has focused on improving patient outcomes in oncology.

Latest Patents

One of his latest patents involves predicting the response to a HER inhibitor. This application describes the use of low HER3 as a selection criterion for treating patients with a HER inhibitor, such as pertuzumab. It also highlights the use of a high HER2:HER3 ratio as a selection criterion for treating cancer patients, including those with ovarian cancer, with a HER inhibitor. Additionally, the application discusses the use of high HER3 as a selection criterion for treating cancer patients with chemotherapeutic agents, such as gemcitabine.

Career Highlights

Throughout his career, Andreas Strauss has worked with prominent companies in the pharmaceutical industry. He has been associated with Hoffmann-La Roche Inc. and Genentech, Inc., where he has contributed to groundbreaking research and development in cancer therapies.

Collaborations

Some of his notable coworkers include Joachim Moecks and Lukas C Amler. Their collaborative efforts have further advanced the research in the field of oncology.

Conclusion

Andreas Strauss continues to be a pivotal figure in the development of innovative cancer treatments. His work not only enhances the understanding of HER inhibitors but also aims to improve the lives of cancer patients worldwide.